Diabetes-Related Deaths Not Decreasing in Rural Areas in the U.S. &nbs p;
| | | To ensure that you never miss an issue, please whitelist us. |
|
|
| | Colleagues assessed the durability and three-year effectiveness of metabolic surgery versus medical and lifestyle management in patients with type 2 diabetes. The analysis included 316 patients (body mass index, 27 to 45 kg/m²) with type 2 diabetes randomly assigned to either surgery (195 patients) or medical and lifestyle therapy (121 patients). |
|
|
TheFIGARO-DKD trial is an international, multicenter, phase 3, randomized, placebo-controlled, double-blind, event-driven clinical trial, in which 7,437 adults (≥18 years old) patients with T2D and Stage 1-4 CKD treated with either ACE-R or ACB at the maximum dose and having serum potassium level of 4.8mmol/L or less at the time of screening were randomized from September 2015 through October 2018. |
| | |
| |
| |
Researchers used the U.S. Centers for Disease Control and Prevention Wide-ranging Online Data for Epidemiologic Research Multiple Cause of Death database to examine trends in diabetes-related mortality (as the underlying or contributing cause of death) in urban and rural U.S. areas (1999 to 2019). |
| | |
|
|
|
